Literature DB >> 4451818

The effect of delta1-tetrahydrocannabinol on the release of (3H-(-)-noradrenaline from the isolated vas deferens of the rat.

J D Graham, M J Lewis, D M Li.   

Abstract

1 The amount of tritium released upon transmural stimulation of the isolated vas of the rat incubated with [(3)H]-Delta(1)-tetrahydrocannabinol (THC) (2.8 muM) was significantly greater than the non-stimulated overflow.2 There was no difference between non-stimulated overflow and the effect of transmural stimulation of vasa equilibrated with [(14)C]-sorbitol (6.5 mg/ml).3 The difference between non-stimulated and stimulated efflux from vasa equilibrated with [(3)H]-Delta(1)-THC was abolished in rats pretreated for 24 h with 6-hydroxydopamine (250 mg/kg).4 The amount of tritium released upon transmural stimulation of the vas incubated with [(3)H]-noradrenaline (6 muM) was significantly greater than the non-stimulated overflow.5 Delta(1)-THC (560 nM and 14 muM) caused a significant dose-dependent reduction of both non-stimulated and stimulated tritium efflux, especially the latter.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4451818      PMCID: PMC1776864          DOI: 10.1111/j.1476-5381.1974.tb09705.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  Cellular studies of sympathetic denervation produced by 6-hydroxydopamine in the vas deferens.

Authors:  J B Furness; G R Campbell; S M Gillard; T Malmfors; J L Cobb; G Burnstock
Journal:  J Pharmacol Exp Ther       Date:  1970-07       Impact factor: 4.030

2.  Comparison of tetrahydrocannabinol and synhexyl in man.

Authors:  L E Hollister; R K Richards; H K Gillespie
Journal:  Clin Pharmacol Ther       Date:  1968 Nov-Dec       Impact factor: 6.875

3.  Role of the central autonomic nervous system in the hypotension and bradycardia induced by (-)-delta 9-trans-tetrahydrocannabinol.

Authors:  R R Vollmer; I Cavero; R J Ertel; T A Solomon; J P Buckley
Journal:  J Pharm Pharmacol       Date:  1974-03       Impact factor: 3.765

4.  Cardiovascular and respiratory effects of cannabis in cat and rat.

Authors:  J D Graham; D M Li
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739

5.  Chemical basis of hashish activity.

Authors:  R Mechoulam; A Shani; H Edery; Y Grunfeld
Journal:  Science       Date:  1970-08-07       Impact factor: 47.728

  5 in total
  8 in total

1.  Proceedings: Delta-tetrahydrocannabinol and adrenergic mechanisms.

Authors:  M J Lewis
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

2.  Cannabis, catecholamines, rapid eye movement sleep and aggressive behaviour.

Authors:  E A Carlini; C J Lindsey; S Tufik
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

3.  Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.

Authors:  M D Adams; L D Chait; J T Earnhardt
Journal:  Br J Pharmacol       Date:  1976-01       Impact factor: 8.739

4.  Do cannabinoids exhibit a tyramine-like effect?

Authors:  Eman Ilayan; Monika Feliszek; Barbara Malinowska; Eberhard Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-07-31       Impact factor: 3.000

5.  The uptake of tritiated delta 1-tetrahydrocannabinol by the isolated vas deferens of the rat.

Authors:  S M Egan; J D Graham; M J Lewis
Journal:  Br J Pharmacol       Date:  1976-04       Impact factor: 8.739

Review 6.  Endocannabinoid modulation of dopamine neurotransmission.

Authors:  Dan P Covey; Yolanda Mateo; David Sulzer; Joseph F Cheer; David M Lovinger
Journal:  Neuropharmacology       Date:  2017-04-25       Impact factor: 5.250

7.  BRL 13776: a novel antihypertensive agent with interesting monoamine depleting properties.

Authors:  J Melrose; M G Palfreyman; R H Poyser; R L Whiting
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

8.  6-Hydroxydopamine and the aggressive behavior induced by marihuana in REM sleep-deprived rats.

Authors:  R E Musty; C J Lindsey; E A Carlini
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.